Thu, Jan 29, 2015, 6:48 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

  • scistats scistats Oct 3, 2013 11:53 AM Flag

    ZLCS 100 PPS+, a very real possibility that all depends on Z160 outcome.

    If ZLCS ever does break the 100 PPS barrier, the reverse split psychological perception will be broken as well. All rests on the outcome of the two pending trials.

    October, 15th is certainly the last patient data collection for postherpetic neuralgia (PHN) in the last six week patient group, and the lumbosacral radiculopathy (LSR) data is already in.

    I think Corrigan believes there is no option but to announce both trials simultaneously as negative news, if released first or last, would have a more negative impact than co-releasing with positive news. Rather than take any risks, he has simply made the decision to co-announce. I think he made this decision some time ago and is sticking with it regardless of the outcome.

    Sentiment: Strong Buy

 
ZLCS
1.180.00(0.00%)Jul 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.